Theranexus Société Anonyme ^Company

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. It has a advanced therapy candidate identification and characterization platform focuses on neurological disorders; and an initial drug candidate in clinical development for Batten disease. The company was founded in 2013 and is based in Lyon, France.